The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRedcentric Regulatory News (RCN)

Share Price Information for Redcentric (RCN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 142.00
Bid: 141.00
Ask: 143.50
Change: -2.25 (-1.56%)
Spread: 2.50 (1.773%)
Open: 144.00
High: 144.00
Low: 142.00
Prev. Close: 144.50
RCN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Share issue in connection with the FY23 Dividend

19 Jan 2024 07:00

RNS Number : 2192A
Redcentric PLC
19 January 2024
 

Redcentric plc

("Redcentric" or the "Company")

 

Share issue in connection with the FY23 Dividend

 

Redcentric (AIM: RCN) a leading UK IT managed services provider, announces that, in respect of the final dividend of 2.4 pence per ordinary share of 0.1 penny each ("Ordinary Shares") for the year ended 31 March 2023 (the "Dividend") due to be paid today, 19 January 2024, the Company has agreed with certain shareholders representing 63.4% of the Company's total voting rights, that its obligation to make payment to them of the Dividend (amounting to, in aggregate, £2,383,145.11) shall be satisfied by the issue of, in aggregate, 1,892,937 new Ordinary Shares (the "Dividend Shares").

 

Having regard to the strategy of the Company, the Board has decided to take this course of action to strengthen cash balances that enable the Company to make strategic decisions in respect of its long-term leases that the Board believe will improve the future profitability of the Company.

 

The Company continues to trade in line with expectations as per the interim announcement on 22 November 2023.

 

The Dividend Shares will be issued at 125.8961 pence per Ordinary Share, being the five-day volume weighted average price of an Ordinary Share] at the close of business on 18 January 2024 (the last business day prior to the dividend payment date). The Dividend Shares will represent in aggregate 1.19% of the enlarged issued share capital of the Company ("ISC").

 

Related Party Transactions

 

Oliver Scott, a Non-Executive Director of the Company, is a partner of, and holds a beneficial interest in, Kestrel Partners LLP ("Kestrel"). Mr. Scott is also a shareholder in Kestrel Opportunities and is therefore deemed to have a beneficial interest in Kestrel Opportunities' entire legal holding in Redcentric.

 

Kestrel and Lombard Odier Asset Management ("Lombard Odier"), both substantial shareholders in the Company, are participating in the Subscription as follows:

Name

Dividend Shares

Kestrel Partners LLP

596,599

Lombard Odier Asset Management

497,160

 

As such, the Subscriptions by Kestrel and Lombard Odier constitute related party transactions pursuant to Rule 13 of the AIM Rules for Companies.

 

The Company's independent directors (being Peter Brotherton, David Senior, Nick Bate and Alan Aubrey) consider, having consulted with the Company's nominated adviser, Cavendish Capital Markets Limited, that the terms of Kestrel's subscription are fair and reasonable insofar as the Company's shareholders are concerned.

 

The Company's directors (being Peter Brotherton, David Senior, Nick Bate, Oliver Scott and Alan Aubrey) consider, having consulted with the Company's nominated adviser, Cavendish Capital Markets Limited, that the terms of Lombard Odier's subscription are fair and reasonable insofar as the Company's shareholders are concerned.

 

Total voting rights

 

Application has been made for the Dividend Shares to be admitted to trading on AIM and it is expected that their admission to AIM will take place on or around 24 January 2024 ("Admission").

 

Following Admission, the Company's ISC will consist of 158,884,919 Ordinary Shares, 655,278 of which remain held in Treasury. For reporting under the FCA's Disclosure Guidance and Transparency Rules, shareholders should exclude any Ordinary Shares held in Treasury and should use the figure of 158,229,641 Ordinary Shares (the issued voting share capital) when determining if they are required to notify their interest, or a change of their interest in the Company.

 

 

Enquiries:

Redcentric plc

Peter Brotherton, Chief Executive Officer

David Senior, Chief Financial Officer

 

+44 (0)800 983 2522

Cavendish Capital Markets Limited - Nomad and Broker

Marc Milmo / Simon Hicks / Charlie Beeson (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

+44 (0)20 7220 0500

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IOEQKFBKDBKBADD
Date   Source Headline
19th Apr 20241:30 pmRNSHolding(s) in Company
5th Apr 20247:00 amRNSExercise of Options
20th Mar 202412:30 pmRNSExercise of Options
4th Mar 20244:00 pmRNSDirector/PDMR Shareholding
29th Feb 20247:00 amRNSDirector/PDMR Shareholding
13th Feb 202412:30 pmRNSDirectorate Change
30th Jan 20244:30 pmRNSDirector/PDMR Shareholding
25th Jan 20244:45 pmRNSDirector/PDMR Shareholding
24th Jan 20246:20 pmRNSExercise of Options
23rd Jan 20244:32 pmRNSDirector/PDMR Shareholding
19th Jan 20247:00 amRNSShare issue in connection with the FY23 Dividend
17th Jan 20245:00 pmRNSDirector/PDMR Shareholding
15th Jan 20244:00 pmRNSDirector/PDMR Shareholding
11th Jan 20249:45 amRNSDirector/PDMR Shareholding
8th Jan 20244:00 pmRNSDirector/PDMR Shareholding
4th Jan 20241:00 pmRNSDirector/PDMR Shareholding
3rd Jan 20249:00 amRNSDirector/PDMR Shareholding
29th Dec 20237:00 amRNSExercise of Options
27th Dec 20233:30 pmRNSDirector/PDMR Shareholding
20th Dec 202312:00 pmRNSDirector/PDMR Shareholding
18th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20234:30 pmRNSDirector/PDMR Shareholding
13th Dec 20237:00 amRNSExercise of Options
11th Dec 202311:00 amRNSDirector/PDMR Shareholding
6th Dec 20237:00 amRNSDirector/PDMR Shareholding
4th Dec 20237:00 amRNSDirector/PDMR Shareholding
23rd Nov 20237:00 amRNSDirector/PDMR Shareholding
22nd Nov 20237:00 amRNSDirectorate Change
22nd Nov 20237:00 amRNSHalf Year Results
20th Oct 20231:23 pmRNSHolding(s) in Company
3rd Oct 20237:00 amRNSExercise of Options
3rd Oct 20237:00 amRNSSave As You Earn Share Option Scheme
28th Sep 20234:00 pmRNSResult of AGM
20th Sep 20234:08 pmRNSGrant of Options and Director/PDMR Shareholding
4th Sep 20237:00 amRNSPublication of Annual Report and Notice of AGM
24th Aug 20237:00 amRNSPreliminary results announcement FY23
17th Aug 20237:00 amRNSNotice of Results
17th Jul 20237:00 amRNSUpdate on Annual Results
28th Apr 20235:08 pmRNSHolding(s) in Company
25th Apr 20237:01 amRNSDirectorate Change
25th Apr 20237:00 amRNSTrading Update
31st Mar 20233:14 pmRNSHolding(s) in Company
22nd Feb 20237:00 amRNSExercise of Options
8th Feb 20237:00 amRNSExercise of Options
11th Jan 20237:00 amRNSExercise of Options
30th Dec 20227:00 amRNSExercise of Options
12th Dec 20227:00 amRNSExercise of Options
8th Dec 20227:00 amRNSHalf Year Results
29th Nov 20223:09 pmRNSHolding(s) in Company
17th Nov 20222:46 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.